BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32166451)

  • 1. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of early proctoscopy in predicting late symptomatic proctitis after external radiation therapy for prostate carcinoma.
    Campostrini F; Musola R; Marchiaro G; Lonardi F; Verlato G
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1031-7. PubMed ID: 22975612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High accumulated doses to the inferior rectum are associated with late gastro-intestinal toxicity in a case-control study of prostate cancer patients treated with radiotherapy.
    Casares-Magaz O; Bülow S; Pettersson NJ; Moiseenko V; Pedersen J; Thor M; Einck J; Hopper A; Knopp R; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1543-1546. PubMed ID: 31364905
    [No Abstract]   [Full Text] [Related]  

  • 4. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2000 Jan; 54(1):11-9. PubMed ID: 10719695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
    Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
    Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.
    Bohrer M; Schröder P; Welzel G; Wertz H; Lohr F; Wenz F; Mai SK
    Strahlenther Onkol; 2008 Dec; 184(12):674-8. PubMed ID: 19107349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy.
    Thor M; Apte A; Deasy JO; Muren LP
    Acta Oncol; 2013 Apr; 52(3):666-75. PubMed ID: 23205746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
    Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients.
    Paleny R; Bremer M; Walacides D; Mainwaring S; Weber K; Henkenberens C
    Strahlenther Onkol; 2019 Feb; 195(2):103-112. PubMed ID: 30191285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
    Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.
    Vassis S; Nöldeke B; Christiansen H; von Klot CA; Merten R
    Strahlenther Onkol; 2020 Jul; 196(7):598-607. PubMed ID: 32040691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy.
    Goldner G; Pötter R; Kranz A; Bluhm A; Dörr W
    Strahlenther Onkol; 2011 Mar; 187(3):202-5. PubMed ID: 21347635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course, intensity-modulated radiotherapy for localized prostate cancer.
    Kupelian PA; Willoughby TR
    Cancer J; 2001; 7(5):421-6. PubMed ID: 11693901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer.
    Ippolito E; Guido A; Macchia G; Deodato F; Giaccherini L; Farioli A; Arcelli A; Cuicchi D; Frazzoni L; Cilla S; Buwenge M; Mantini G; Alitto AR; Nuzzo M; Valentini V; Ingrosso M; Morganti AG; Fuccio L
    In Vivo; 2017; 31(5):961-966. PubMed ID: 28882966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer.
    Zelefsky MJ; Pinitpatcharalert A; Kollmeier M; Goldman DA; McBride S; Gorovets D; Zhang Z; Varghese M; Happersett L; Tyagi N; Hunt M
    Eur Urol Oncol; 2020 Dec; 3(6):748-755. PubMed ID: 31668713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
    Thor M; Deasy JO; Paulus R; Robert Lee W; Amin MB; Bruner DW; Low DA; Shah AB; Malone SC; Michalski JM; Dayes IS; Seaward SA; Gore EM; Albert M; Pisansky TM; Faria SL; Chen Y; Koontz BF; Swanson GP; Pugh SL; Sandler HM
    Radiother Oncol; 2019 Jun; 135():19-24. PubMed ID: 31015166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicity.
    Peterson JL; Buskirk SJ; Heckman MG; Diehl NN; Bernard JR; Tzou KS; Casale HE; Bellefontaine LP; Serago C; Kim S; Vallow LA; Daugherty LC; Ko SJ
    Med Dosim; 2014; 39(1):12-7. PubMed ID: 24099966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.